Policy/Enforcement News
Four things Congress should do for patient safety in the rest of the 119th
This post outlines practical steps Congress should take to strengthen pharmaceutical border security, reinforce regulatory oversight, and protect patients.
[...]Prescription Drug Affordability Board Activity, December 2025
Prescription Drug Affordability Board Activity, December 2025 Activities Summary Colorado: In October, Colorado’s PDAB heard testimony about its decision to set an upper payment limit on Enbrel, and set price of $600 per 50mg/1ml, effective January 1, 2027. The board’s next meeting is January 9, 2026. Maryland:The PDAB met on December 8, 2025 to review…
[...]PSM endorses Iowa HSB 591 to strengthen med spa oversight for Iowans
The bill will protect Iowa’s patients by closing enormous regulatory gaps in the med spa and wellness industry.
[...]In July, Google promised to rid their platform of criminals selling pill presses. How’s it going?
As of the first week of January, we found several companies with multiple ads still running well past its self-imposed deadline. Google can do better, but will they?
[...]Prescription Drug Affordability Board Activity, November 2025
Prescription Drug Affordability Board Activity, November 2025 Activities Summary Colorado: In October, Colorado’s PDAB heard testimony about its decision to set an upper payment limit on Enbrel, and set price of $600 per 50mg/1ml, effective January 1, 2027. The board’s next meeting is January 9, 2026. Maryland:The PDAB met on November 17, 2025 where they…
[...]Intelligence Alert: Unlicensed med spas are selling unregulated diabetes and weight loss injectables that threaten public safety
Based on recent investigative reporting by the Partnership for Safe Medicines (PSM), patients in your state may be receiving weight loss injectables from unlicensed sources that do not meet FDA requirements for safety and sterility. PSM has established a dedicated contact from CBP/HSI to support investigations by state law enforcement on this issue.
[...]Prescription Drug Affordability Board Activity, October 2025
Prescription Drug Affordability Board Activity, October 2025 Activities Summary Colorado: Colorado’s PDAB heard testimony about its decision to set an upper payment limit on Enbrel, and set price of $600 per 50mg/1ml, effective January 1, 2027. The board’s next meeting was rescheduled from November 14, 2025 to January 9, 2026. Maryland: The PDAB will next…
[...]Five takeaways from CNBC’s investigation of alternative funding programs
What are the most important lessons from CNBC’s documentary about alternative funding programs (AFPs)?
[...]PSM asks House Energy & Commerce Committee to oppose H.R. 5316, The Drug Shortage Compounding Patient Access Act
PSM sent a letter explaining how H.R. 5316 undermines critical patient safety protections.
[...]Prescription Drug Affordability Board Activity, September 2025
Prescription Drug Affordability Board Activity, September 2025 Activities Summary Colorado: Colorado’s next meeting will be October 3, 2025. Maryland: The PDAB met on September 29, 2025 to hear public comment about UPL-setting for Jardiance and Farxiga and to consider policy approaches to lower the costs of these drugs for Maryland patients. Oregon: The PDAB met…
[...]